Publication date: Dec 08, 2020 The impact of a focused inpatient educational intervention on rates of medication-assisted therapy (MAT) for veterans with opioid use disorder (OUD) was evaluated. A retrospective ... Read more

Publication date: Dec 04, 2020 Open Access PDF Concepts Keywords Opioid Ketones Veterans Administration Psychoactive drugs Opioid Morphine Opioid antagonists Neurochemistry Semantics Type Source Name disease MESH Development drug DRUGBANK ... Read more

Publication date: Dec 03, 2020 Today, COVID-19 is spreading around the world. Information about its mechanism, prognostic factors, and management is minimal. COVID-19, as a human disease, has several identifying ... Read more

Publication date: Dec 04, 2020 The kappa opioid receptor (KOR)-related ligands have been demonstrated in preclinical studies for several therapeutic potentials. This chapter highlights (1) how non-human primates (NHP) studies ... Read more

Publication date: Dec 04, 2020 The opioid crisis has continued to progress in the United States and the rest of the world. As this crisis continues, there is a pressing ... Read more

Publication date: Dec 04, 2020 Drug overdoses have tripled in the United States over the last two decades. With the increasing demand for donor organs, one potential consequence of the ... Read more

Publication date: Dec 04, 2020 The proliferation of misuse of prescription and non-prescription opioids, in recent years, has caused an opioid epidemic in the United States. Forensic toxicology laboratories often ... Read more

Publication date: Dec 02, 2020 Skin and soft tissue infections (SSTIs) are among the leading causes of morbidity and mortality for people who inject drugs (PWID). Studies demonstrate that certain ... Read more

Publication date: Dec 03, 2020 Research has examined the effect of Medicaid expansion on access to physicians with buprenorphine waivers, but less attention has been paid to Medicaid’s impact on ... Read more

Publication date: Dec 01, 2020 It is not known whether decreases in Schedule II (high abuse potential) vs Schedule IV (lower abuse potential) opioid prescriptions overall and among high-risk patients ... Read more